China's Concord Medical Services H1 net loss narrows

Reuters

Sep 26

China's Concord Medical Services H1 net loss narrows

Overview

Concord Medical's H1 2025 revenue falls 8.3% yr/yr to RMB200.6 mln (US$28.0 million)
Net loss narrows to RMB27.1 mln (US$3.8 million) from RMB172.3 mln last year
Hospital business revenue up 11.1% due to proton therapy operations at Guangzhou Concord Cancer Hospital

Outlook

Company to advance proton therapy and enhance precision radiotherapy understanding
Concord Medical aims to expand access to advanced diagnostic technologies
Company plans to strengthen patient confidence in precision radiotherapy
Concord Medical committed to improving patient access to innovative medications

Result Drivers

PROTON THERAPY - Hospital business revenue increased by 11.1% due to the commencement of proton therapy operations at Guangzhou Concord Cancer Hospital
NETWORK BUSINESS DECLINE - Network business revenue fell 41.3% due to decreased demand for medical equipment and software and non-renewal of expired contracts
COST EFFICIENCY - Gross loss margin improved due to adjustments in revenue structure and strategic focus on enhancing operational efficiency and reducing costs

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
H1 Revenue		RMB 200.60 mln
H1 EPS		RMB 0.21
H1 Net Income		-RMB 27.10 mln
H1 Adjusted EBITDA		-RMB 62.20 mln

Press Release: ID:nPnbGX85Ba

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2570888866"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2570888866\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2570888866?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-26 19:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2570888866","market":"fut","top_or_hot":-1,"title":"China's Concord Medical Services H1 net loss narrows","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>China's Concord Medical Services H1 net loss narrows </title></head><body><p><span>Overview</span></p><ul><li><p>Concord Medical's H1 2025 revenue falls 8.3% yr/yr to RMB200.6 mln  (US$28.0 million)</p></li><li><p>Net loss narrows to RMB27.1 mln (US$3.8 million) from RMB172.3 mln last year</p></li><li><p>Hospital business revenue up 11.1% due to proton therapy operations at Guangzhou Concord Cancer Hospital</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company to advance proton therapy and enhance precision radiotherapy understanding</p></li><li><p>Concord Medical aims to expand access to advanced diagnostic technologies</p></li><li><p>Company plans to strengthen patient confidence in precision radiotherapy</p></li><li><p>Concord Medical committed to improving patient access to innovative medications</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>PROTON THERAPY - Hospital business revenue increased by 11.1% due to the commencement of proton therapy operations at Guangzhou Concord Cancer Hospital</p></li><li><p>NETWORK BUSINESS DECLINE - Network business revenue fell 41.3% due to decreased demand for medical equipment and software and non-renewal of expired contracts</p></li><li><p>COST EFFICIENCY - Gross loss margin improved due to adjustments in revenue structure and strategic focus on enhancing operational efficiency and reducing costs</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>H1 Revenue</p></td><td></td><td><p>RMB 200.60 mln</p></td><td></td></tr><tr><td><p>H1 EPS</p></td><td></td><td><p>RMB 0.21</p></td><td></td></tr><tr><td><p>H1 Net Income</p></td><td></td><td><p>-RMB 27.10 mln</p></td><td></td></tr><tr><td><p>H1 Adjusted EBITDA</p></td><td></td><td><p>-RMB 62.20 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nPnbGX85Ba</span></p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China's Concord Medical Services H1 net loss narrows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina's Concord Medical Services H1 net loss narrows\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-26 19:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>China's Concord Medical Services H1 net loss narrows </title></head><body><p><span>Overview</span></p><ul><li><p>Concord Medical's H1 2025 revenue falls 8.3% yr/yr to RMB200.6 mln  (US$28.0 million)</p></li><li><p>Net loss narrows to RMB27.1 mln (US$3.8 million) from RMB172.3 mln last year</p></li><li><p>Hospital business revenue up 11.1% due to proton therapy operations at Guangzhou Concord Cancer Hospital</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company to advance proton therapy and enhance precision radiotherapy understanding</p></li><li><p>Concord Medical aims to expand access to advanced diagnostic technologies</p></li><li><p>Company plans to strengthen patient confidence in precision radiotherapy</p></li><li><p>Concord Medical committed to improving patient access to innovative medications</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>PROTON THERAPY - Hospital business revenue increased by 11.1% due to the commencement of proton therapy operations at Guangzhou Concord Cancer Hospital</p></li><li><p>NETWORK BUSINESS DECLINE - Network business revenue fell 41.3% due to decreased demand for medical equipment and software and non-renewal of expired contracts</p></li><li><p>COST EFFICIENCY - Gross loss margin improved due to adjustments in revenue structure and strategic focus on enhancing operational efficiency and reducing costs</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>H1 Revenue</p></td><td></td><td><p>RMB 200.60 mln</p></td><td></td></tr><tr><td><p>H1 EPS</p></td><td></td><td><p>RMB 0.21</p></td><td></td></tr><tr><td><p>H1 Net Income</p></td><td></td><td><p>-RMB 27.10 mln</p></td><td></td></tr><tr><td><p>H1 Adjusted EBITDA</p></td><td></td><td><p>-RMB 62.20 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nPnbGX85Ba</span></p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CCM","symbol_name":"泰和诚医疗","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nPLXF393A1:1","article_id":"2570888866","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2570888866","pubTimestamp":1758886974,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"China's Concord Medical Services H1 net loss narrowsOverviewConcord Medical's H1 2025 revenue falls 8.3% yr/yr to RMB200.6 mln  (US$28.0 million)Net loss narrows to RMB27.1 mln (US$3.8 million) from R","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CCM":"泰和诚医疗","BK4503":"景林资产持仓","BK4196":"保健护理服务"},"translate_title":"中国协和医疗服务上半年净亏损收窄","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CCM":0.9},"content_text":"China's Concord Medical Services H1 net loss narrows OverviewConcord Medical's H1 2025 revenue falls 8.3% yr/yr to RMB200.6 mln  (US$28.0 million)Net loss narrows to RMB27.1 mln (US$3.8 million) from RMB172.3 mln last yearHospital business revenue up 11.1% due to proton therapy operations at Guangzhou Concord Cancer HospitalOutlookCompany to advance proton therapy and enhance precision radiotherapy understandingConcord Medical aims to expand access to advanced diagnostic technologiesCompany plans to strengthen patient confidence in precision radiotherapyConcord Medical committed to improving patient access to innovative medicationsResult DriversPROTON THERAPY - Hospital business revenue increased by 11.1% due to the commencement of proton therapy operations at Guangzhou Concord Cancer HospitalNETWORK BUSINESS DECLINE - Network business revenue fell 41.3% due to decreased demand for medical equipment and software and non-renewal of expired contractsCOST EFFICIENCY - Gross loss margin improved due to adjustments in revenue structure and strategic focus on enhancing operational efficiency and reducing costsKey DetailsMetricBeat/MissActualConsensus EstimateH1 RevenueRMB 200.60 mlnH1 EPSRMB 0.21H1 Net Income-RMB 27.10 mlnH1 Adjusted EBITDA-RMB 62.20 mlnPress Release: ID:nPnbGX85Ba(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}